This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sequenom Inc (SQNM)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -16.33M 1.01M -107.41M -117.03M
Operating Gains/Losses -21.72M -42.80M 2.36M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 2.71M -6.58M -2.30M -879.00K
(Increase) Decrease in Inventories 4.10M 5.08M -6.17M -525.00K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -7.64M -5.68M -90.00K 13.42M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital -1.41M -1.58M 752.00K -390.00K
Other Non-Cash Items 8.71M 11.74M 12.28M 14.78M
Net Cash From Continuing Operations -20.20M -28.25M -85.64M -78.01M
Net Cash From Discontinued Operations 0.00 2.82M 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -20.20M -25.43M -85.64M -78.01M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 30.00M 0.00 95.39M 60.93M
Purchases of Property, Plant & Equipment -2.07M -11.49M -12.71M -15.23M
Acquisitions 0.00 29.29M 0.00 0.00
Purchases of Short-Term Investments -25.19M -45.13M -52.83M -57.74M
Other Cash from Investing Activities 7.75M 36.16M -483.00K -1.89M
Cash Provided by Financing Activities
Net Cash From Investing Activities 10.49M 32.88M 29.37M -13.93M
Issuance of Debt 0.00 0.00 0.00 130.12M
Cash Used for Financing Activities
Issuance of Capital Stock 932.00K 1.83M 1.93M 59.28M
Repayment of Long-Term Debt -4.14M -7.54M -7.57M -2.63M
Repurchase of Capital Stock 0.00 0.00 -455.00K 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 0.00 0.00
Net Cash From Financing Activities -3.21M -5.71M -6.10M 186.77M
Effect of Exchange Rate Changes -43.00K -18.00K 157.00K 51.00K
Net Change in Cash & Cash Equivalents -12.96M 1.72M -62.21M 94.88M
SQNM News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for SQNM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 1
GET SQNM ANALYST REPORT

SQNM Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs